Package Insert: Information for the Patient
Duloxetina Krka 60 mg Hard Capsules EFG
Read this package insert carefully before you start taking this medicine, because it contains important information for you.
DuloxetinaKrkacontains the active ingredient duloxetina. Duloxetina increases the levels of serotonin and noradrenalina in the nervous system.
Duloxetina is used in adults to treat:
Duloxetina begins to take effect in most people with depression or anxiety within two weeks of starting treatment, but it may take between 2 and 4 weeks to start feeling better. Inform your doctor if you do not notice improvement after this time. Your doctor may continue to give you duloxetina when you are feeling better to prevent your depression or anxiety from returning.
In people with diabetic neuropathic pain, it may take several weeks to start feeling better. Consult your doctor if you do not feel better after 2 months.
Do not take Duloxetina Krka
Consult your doctor if you have high blood pressure or heart disease. Your doctor will tell you if you should take duloxetine.
Warnings and precautions
Duloxetine may not be suitable for you for the following reasons. Consult your doctor before starting to take this medicine if:
You should also contact your doctor:
if you experience signs and symptoms of restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhoea, coma, nausea, vomiting, as you may be suffering from serotonin syndrome.
In its most severe form, serotonin syndrome can resemble Malignant Neuroleptic Syndrome (MNS). The signs and symptoms of MNS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by blood test).
Some medicines in the same group as Duloxetina Krka (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
Duloxetina Krka may cause a feeling of restlessness or inability to sit or stay still. If this happens, you should tell your doctor.
Thoughts of suicide and worsening of depression or anxiety
If you are depressed and/or have anxiety disorders, you may occasionally have thoughts of self-harm or suicide. These thoughts may be increased at the beginning of treatment with antidepressants, as all these medicines take time to work, usually two weeks but sometimes longer.
You are more likely to have these thoughts if:
Contact your doctor or go directly to the hospital as soon as you have any thoughts of self-harm or suicide.
It may be helpful to tell a close friend or family member that you are depressed or have an anxiety disorder, and ask them to read this leaflet. They may be able to tell you if your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.
Children and adolescents under 18 years
Duloxetine is usually not used in children and adolescents under 18 years. You should also know that young patients taking this class of medicines have an increased risk of side effects such as suicidal thoughts, suicidal behaviour and hostility (mainly aggression, oppositional behaviour and irritability). Despite this, your doctor may prescribe duloxetine for patients under 18 years because they decide it may be beneficial for the patient. If your doctor has prescribed duloxetine for a patient under 18 years and you want to talk about it, please go back to the doctor. You should tell your doctor if any of the symptoms mentioned above appear or get worse in patients under 18 years who are taking duloxetine. Also, in this age group, the long-term safety effects of duloxetine related to growth, maturation and cognitive and behavioural development have not yet been demonstrated.
Other medicines and Duloxetina Krka
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine, including those bought without a prescription.
The main component of Duloxetina Krka, duloxetine, is used in other medicines for other treatments:
You should avoid using more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetine.
Your doctor will decide if you can take duloxetine with other medicines.Do not start or stop using any medicine, including those bought without a prescription, without first consulting your doctor.
You should also tell your doctor if you are taking any of the following medicines:
Monoamine oxidase inhibitors (MAOIs):do not take duloxetine if you are taking, or have taken in the last 14 days, another antidepressant known as a monoamine oxidase inhibitor (MAOI). Examples of MAOIs include moclobemide (an antidepressant) and linezolid (an antibiotic). Taking an MAOI with many prescription medicines, including duloxetine, may cause serious side effects, even life-threatening. You should wait at least 14 days after stopping treatment with an MAOI before taking duloxetine. Similarly, you should wait at least 5 days after stopping treatment with duloxetine before starting treatment with an MAOI.
Medicines that cause drowsiness:This includes prescription medicines prescribed by your doctor such as benzodiazepines, powerful analgesics, antipsychotics, phenobarbital and antihistamines.
Medicines that increase serotonin levels:Triptans, buprenorphine (a medicine for pain or opioid dependence), tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine), tricyclic antidepressants (such as clomipramine and amitriptyline), petidina, St. John's Wort and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of causing side effects such as serotonin syndrome (see “Warnings and precautions” and “Possible side effects”). If you notice any unusual symptoms when using any of these medicines with duloxetine, you should tell your doctor.
Oral anticoagulants or antiplatelet agents:Medicines that thin the blood or prevent the formation of blood clots in the blood. These medicines may increase the risk of bleeding.
Taking Duloxetina Krka with food, drinks and alcohol
Duloxetine can be taken with or without food. You should be careful if you take alcohol while taking duloxetine.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
During treatment with duloxetine, you may feel drowsy or dizzy. Do not drive or operate tools or machines until you know how duloxetine affects you.
Duloxetina Krka contains saccharose
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Duloxetine should be taken orally. Swallow the capsule whole with water.
For depression and diabetic neuropathic pain:
The recommended dose of duloxetine is 60 mg once a day, but your doctor will prescribe the dose that is best for you.
For generalized anxiety disorder:
The initial normal dose of duloxetine is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose can be adjusted to 120 mg per day depending on your response to duloxetine.
To avoid forgetting to take duloxetine, it may be helpful to take it at the same time every day.
Discuss with your doctor for how long you should take duloxetine. Do not stop taking duloxetine, or change your dose without consulting your doctor. It is essential to treat your condition properly to help you improve. If you do not treat it, your condition may not disappear and may become more severe and harder to treat.
If you take more Duloxetine Krka than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91.562.04.20 indicating the medication and the amount ingested.
Among the symptoms produced by an overdose are drowsiness, coma, serotonin syndrome (a rare reaction that can cause a feeling of intense happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle rigidity) seizures, vomiting, and high heart rate.
If you forgot to take Duloxetine Krka
If you forget to take a dose, take it as soon as you remember. However, if it is time for the next dose, skip the missed dose and take a single dose as you normally do. Do not take a double dose to compensate for the missed doses. Do not take more duloxetine than prescribed for you in a day.
If you interrupt treatment with Duloxetine Krka
DO NOT stop taking your capsules without consulting your doctor, even if you feel better. If your doctor thinks you no longer need to take duloxetine, they will instruct you to reduce your dose for at least 2 weeks before stopping treatment.
Some patients who have stopped duloxetine treatment abruptly have presented symptoms such as:
These symptoms are usually not significant and disappear within a few days, but if you have symptoms that are bothersome, ask your doctor for advice.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. These side effects are usually mild to moderate and often disappear within a few weeks.
Very common side effects (may affect more than 1 in 10 patients)
Common side effects (may affect up to 1 in 10 patients)
Children and adolescents under 18 years of age with depression treated with this medicine experienced a decrease in weight when they started taking this medicine. After 6 months of treatment, the weight increased to similar levels as other children and adolescents of the same age and sex.
Uncommon side effects (may affect up to 1 in 100 patients)
Rare side effects (may affect up to 1 in 1,000 patients)
Very rare side effects (may affect up to 1 in 10,000 patients)
-inflammation of blood vessels in the skin (cutaneous vasculitis).
Unknown frequency (cannot be estimated from available data)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system: Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es.
By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Store in the original packaging to protect it from moisture.
Medicines should not be disposed of through drains or in the trash. Deposit the packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Duloxetine Krka Composition
Capsule Content:sugar spheres (maize starch and sucrose), hypromellose 6Cp, sucrose, hypromellose phthalate, talc (E553b) and triethyl citrate (E1505)
Capsule Coating:gelatin (E441), titanium dioxide (E171), indigotin (E132),yellow iron oxide (E172),ink (shellac (E904), black iron oxide (E172)).
See section 2 “Duloxetine Krka contains sucrose”.
Appearance of the Product and Contents of the Package
White to almost white granule in a hard gelatin capsule size 1. The capsule body is yellowish green and the cap is dark blue. The capsule body is printed with 60 in black.
Duloxetine Krka is available in packs of 7 and 28 gastro-resistant hard capsules in blisters.
Only some package sizes may be marketed.
Marketing Authorization Holder and Responsible Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
For more information about this medicinal product, please contact the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Member State | Medicinal Product Name |
Slovakia | Duloxetin Krka, d.d., Novo mesto 60 mg tvrdé |
France | DuloxétineKrka 60 mggélule gastro-résistante |
Italy | Duloxetine Krka |
Spain | Duloxetina Krka 60 mg cápsulas duras gastrorresistentes EFG |
Last review date of this leaflet: September 2024
For detailed information about this medicinal product, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.